Eurobio Scientific Société anonyme (FRA:E8TN)

Germany · Delayed Price · Currency is EUR

21.50

-0.30 (-1.38%)

At close: Jun 26, 2026

-14.00% (1Y)

Market Cap	217.47M -15.0%
Revenue (ttm)	168.60M +9.1%
Net Income	4.87M +21.7%
EPS	0.47 +20.5%
Shares Out	n/a
PE Ratio	44.70
Forward PE	18.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	21.50
Previous Close	21.80
Day's Range	21.50 - 21.50
52-Week Range	20.40 - 25.75
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 1, 2026

About FRA:E8TN

Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The company produces and markets transport and preservation media for corneal grafts; AlloMap, for heart transplant follow up; cell culture media, molecular biology reagents, contract manufacturing service, and proprietary antibodies; TQS (Tetanus Quick Stick), a rapid test used in emergency departments or pharmacies to assess the vaccina... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1997

Employees 343

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol E8TN

Financial Performance

In 2025, FRA:E8TN's revenue was 168.60 million, an increase of 9.08% compared to the previous year's 154.56 million. Earnings were 4.87 million, an increase of 21.69%.

Financial Statements